1-bromo-2,2,4-trimethylpentane | 13356-11-1

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机溴化物
• 英文名称: 1-bromo-2,2,4-trimethylpentane
• 英文别名: 1-Brom-2,2,4-trimethyl-pentan
• CAS: 13356-11-1
• 化学式: C₈H₁₇Br
• 分子量: 193.127
• InChiKey: NMVOMRIFNKHAJT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为产物：
  描述：

  2,2,4-三甲基-1-戊醇 在 三丁基膦 、 溴 作用下， 生成 1-bromo-2,2,4-trimethylpentane
  参考文献：
  名称：

  Sterically Hindered Group IVa Organometallics. VI.¹ Preparation and Some Properties of Neophyltins and Related Compounds

  摘要：

  DOI：

  10.1021/jo01349a515

文献信息

• [EN] TARGETED DELIVERY AND PRODRUG DESIGNS FOR PLATINUM-ACRIDINE ANTI-CANCER COMPOUNDS AND METHODS THEREOF<br/>[FR] ADMINISTRATION CIBLÉE ET CONCEPTIONS DE PROMÉDICAMENTS POUR COMPOSÉS ANTICANCÉREUX À BASE DE PLATINE ET D'ACRIDINE ET MÉTHODES ASSOCIÉES
  申请人：WAKE FOREST SCHOOL OF MEDICINE

  公开号：WO2013033430A1

  公开（公告）日：2013-03-07

  Acridine containing cispiaiin compounds have been disclosed that show greater efficacy against cancer than other cisplatin compounds. Methods of delivery of those more effective eisp!aiin compounds to the nucleus in cancer ceils is disclosed using one or more amino acids, one or more sugars, one or more polymeric ethers, C i^aikylene-phenyl-NH-C(0)-R.15, folic acid, av03 iniegriii RGD binding peptide, tamoxifen, endoxifen, epidermal growth factor receptor, antibody conjugates, kinase inhibitors, diazoles, triazol.es, oxazoies, erlotinib, and/or mixtures thereof; wherein R]§ is a peptide.

  含有环丙啶结构的吖啶类化合物已被披露，显示出比其他顺铂类化合物更有效地对抗癌症。使用一种或多种氨基酸、一种或多种糖、一种或多种聚合醚、C i^aikylene-phenyl-NH-C(0)-R.15、叶酸、av03整合RGD结合肽、他莫昔芬、恩多西芬、表皮生长因子受体、抗体结合物、激酶抑制剂、二唑类化合物、三唑类化合物、噁唑类化合物、厄洛替尼和/或它们的混合物将这些更有效的吖啶类化合物传递到癌细胞核中的方法被披露；其中R]§是一个肽。
• Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink
  申请人：DIC Corporation

  公开号：US11079675B2

  公开（公告）日：2021-08-03

  A novel compound is used as a novel photopolymerization initiator, the novel compound having a molecular structure represented by general formula 1 below [R1 represents an alkyl group having 1 to 10 carbon atoms, R2 represents an alkyl group having 1 to 12 carbon atoms or the like, R3 represents an alkyl group having 1 to 12 carbon atoms or the like, R4 to R7 each independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, or the like, Y1 represents an alkyl group having 3 to 19 carbon atoms or the like, Y2 represents an organic linking group, X1 represents an ethylene group or the like, X2 and X3 each represent an ethylene group or the like, Y3 represents a single bond or an alkylidene group, and n represents an integer of 1 to 3].

  一种新型化合物被用作新型光聚合引发剂，该新型化合物的分子结构如下通式 1 所示 [R1 代表具有 1 至 10 个碳原子的烷基，R2 代表具有 1 至 12 个碳原子的烷基或类似物，R3 代表具有 1 至 12 个碳原子的烷基或类似物，R4 至 R7 各自独立地代表氢原子、具有 1 至 8 个碳原子的烷基或类似物、Y1 代表具有 3 至 19 个碳原子的烷基或类似基团，Y2 代表有机连接基团，X1 代表乙烯基或类似基团，X2 和 X3 各自代表乙烯基或类似基团，Y3 代表单键或亚烷基，n 代表 1 至 3 的整数]。
• Sterically Hindered Group IVa Organometallics. VI.¹ Preparation and Some Properties of Neophyltins and Related Compounds
  作者：Hans Zimmer、Otto A. Homberg、Madhusudan Jayawant

  DOI：10.1021/jo01349a515

  日期：1966.11
• NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PRINTING INK, AND PRINTED MATTER SURING THE PRINTING INK
  申请人：DIC Corporation

  公开号：US20190137872A1

  公开（公告）日：2019-05-09

  A novel compound is used as a novel photopolymerization initiator, the novel compound having a molecular structure represented by general formula 1 below [R 1 represents an alkyl group having 1 to 10 carbon atoms, R 2 represents an alkyl group having 1 to 12 carbon atoms or the like, R 3 represents an alkyl group having 1 to 12 carbon atoms or the like, R 4 to R 7 each independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, or the like, Y 1 represents an alkyl group having 3 to 19 carbon atoms or the like, Y 2 represents an organic linking group, X 1 represents an ethylene group or the like, X 2 and X 3 each represent an ethylene group or the like, Y 3 represents a single bond or an alkylidene group, and n represents an integer of 1 to 3].
• [EN] FUSED BICYCLIC PYRIMIDINES AS PTK INHIBITORS CONTAINING A ZINC BINDING MOIETY<br/>[FR] PYRIMIDINES BICYCLIQUES FUSIONNÉES SERVANT D'INHIBITEURS DE PTK CONTENANT UN GROUPE DE LIAISON AU ZINC
  申请人：CURIS INC

  公开号：WO2008033745A2

  公开（公告）日：2008-03-20

  [EN] The present invention relates to fused bicyclic pyrimidine containing zinc- binding moiety based derivatives that have unique properties as protein tyrosine kinase (PTK) inhibitors and their use in the treatment of PTK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.
  [FR] L'invention concerne une pyrimidine bicyclique fusionnée présentant des propriétés uniques, contenant des dérivés fondés sur un groupe de liaison au zinc. Les pyrimidines de l'invention servent d'inhibiteurs de la protéine tyrosine kinase (PTK). L'invention concerne également un procédé d'utilisation de ces pyrimidines visant à traiter des maladies associées à PTK et des troubles comme le cancer. Les dérivés susmentionnés peuvent également servir d'inhibiteurs de l'histone désacétylase (HDAC).